Effects of Chiropractic on Chronic Cancer-related Fatigue

Cancer Clinical Trial

— CAN  

Official title:

The Effects of Upper Cervical Chiropractic Care in Adult Cancer Survivors With Chronic Cancer-related Fatigue: a Feasibility Trial

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06235671
• Other study ID #: I-0029
• Status: Not yet recruiting
• Phase: N/A
• Start date: March 1, 2024
• Est. completion date: December 31, 2024

Study information

• Verified date: January 2024
• Source: Life University
• Contact: Austin Garlinghouse
• Phone: 770-426-2639
• Email: research.studies[@]life.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The primary aims of the proposed trial are centered around examining the feasibility of conducting a prospective, chiropractic intervention study on a population of cancer survivors living in and around Atlanta, Georgia. This includes evaluating various implementation outcomes including recruitment, adherence, tolerability, retention, acceptability, and data fidelity. The results of this trial will inform the design of a future randomized controlled trial (RCT) that has an increased focus on the efficacy/effectiveness of chiropractic care on chronic cancer-related fatigue (CCRF) and other cancer-related sequelae in cancer survivors.

Description:

Cancer remission is often marked by the cessation of curative-intent treatments (e.g., surgery, chemotherapy, radiotherapy, immunotherapy), however, troublesome signs and symptoms (e.g., fatigue, depression, cognitive impairment, dysautonomia) related to the cancer and its treatments commonly persist for prolonged periods (i.e., months to years). Of these, chronic cancer-related fatigue (CCRF) is one of the most frequently reported and debilitating symptoms. CCRF may be characterized as tiredness or exhaustion persisting for 3 or more months following the completion of the primary curative-intent cancer therapies which is independent on one's quantity or quality of rest and causes impairments in daily functioning and quality of life. Notably, although the mechanisms underlying CCRF are still unclear, there is some evidence that it may be related to autonomic dysregulation.

Irrespective of the cause(s), lack of identification of and treatment for CCRF and other chronic cancer-related sequelae is commonplace. Further, empirical data supporting the efficacy of interventions to remediate these issues are relatively sparse and urgently needed as the global population of cancer survivors continues to increase. Of note, although there is no universally accepted definition of 'cancer survivor', the investigators define it here as someone who has completed their primary curative-intent therapies and is cancer-free (i.e., has no evidence of active disease). This definition is in line with that of the European Organisation of Research & Treatment of Cancer (EORTC) Survivorship Task Force and the EORTC Quality of Life Group.

Interestingly, a recent study suggested that a single chiropractic adjustment may mitigate lower extremity muscular fatigue during isometric exercise in young, healthy males. However, to the investigators' knowledge, the impact of chiropractic care on CCRF and other health-related challenges that burden cancer survivors has yet to be investigated.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 20
• Est. completion date: December 31, 2024
• Est. primary completion date: September 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Able to understand and provide written informed consent in English

• 18-65 years of age

• Informed by primary health care provider that there is no evidence of active disease (this is sometimes referred to as "complete remission" or "cured")

• Minimum of 3 months since completion of primary curative-intent cancer therapies including surgery, chemotherapy, radiotherapy, and/or immunotherapy (long-term hormonal therapy permitted)

• Onset of fatigue occurred at some point during illness and/or treatment

• FACIT-Fatigue scale score in the moderate-to-severe range (i.e., at or above the 60th percentile)

• If on any prescription medication (including hormonal therapy), on a stable dose for a minimum of 12 weeks with no plans to change medications or doses during the study

Exclusion Criteria:

• Taking any short-acting benzodiazepine including midazolam & triazolam

• Known disorder resulting in syncope/fainting during postural changes (e.g., postural orthostatic tachycardia syndrome, orthostatic hypotension)

• Pacemaker or known heart condition that influences the electrical or mechanical function of the heart (e.g., severe heart valve disease)

• Diagnosed with an externalizing (e.g., substance use, antisocial disorder) or thought (e.g., schizophrenia, paranoid personality, bipolar) disorder that is uncontrolled or untreated

• Diagnosed with rheumatoid arthritis, osteoporosis, or cervical spine instability

• Currently pregnant

• Current litigation related to a physical, health-related injury

• Chronic pain rated at least 3/10 on a visual analog scale (VAS)

Related Conditions & MeSH terms

• Cancer
• Fatigue

Intervention

Procedure:
• Chiropractic care
6 weeks of chiropractic care

Locations

Country	Name	City	State
United States	Dr. Sid E. Williams Center for Chiropractic Research	Atlanta	Georgia

Sponsors (1)

Lead Sponsor	Collaborator
Life University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Participant recruitment	Average number of participants recruited/enrolled per month	6-month data collection period
Primary	Participant scheduling	Average time lag between first lab assessment & first chiropractic visit	6-month data collection period
Primary	Participant compliance	Proportion of participants violating 1 or more pre-assessment lifestyle restrictions & unable/unwilling to be rescheduled	6-month data collection period
Primary	Participant adherence	Proportion of participants not attending at least 80% of their chiropractic sessions	6-month data collection period
Primary	Participant tolerability	Proportion of participants unable/unwilling to complete a given assessment	6-month data collection period
Primary	Participant retention	Proportion of participants completing the trial	6-month data collection period
Primary	Assessment acceptability	Most common patient-related acceptability score for each assessment process/procedure	6-month data collection period
Primary	Data fidelity	Proportion of acquisitions from a given assessment that are unsuitable for analysis	6-month data collection period
Primary	Implementation acceptability	Most common clinician-rated acceptability score for each trial process/procedure	6-month data collection period